• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[住院慢性阻塞性肺疾病患者的死亡率和合并症]

[Mortality and comorbidity in hospitalized chronic obstructive pulmonary disease patients].

作者信息

Rubinsztajn Renata, Chazan Ryszarda

机构信息

Analiza przyczyn zgonów i chorób współistniejących u hospitalizowanych chorych na przewlekłą obturacyjną chorobę płuc.

出版信息

Pneumonol Alergol Pol. 2011;79(5):343-6.

PMID:21861258
Abstract

INTRODUCTION

Chronic obstructive pulmonary disease (COPD) is a fourth cause of death in USA and is expected to be the third cause of death by year 2020. It is believed that some diseases like cardiovascular diseases, osteoporosis, cachexia, anaemia are systemic consequences of COPD. Some data show that the co-morbidities are more frequent in severe COPD patients than in control groups and are associated with the serious health outcomes. It is debated whether extra pulmonary comorbidities or pulmonary complications are the main reason of death in COPD. The aim of the study was to analyze the mortality and comorbidity in COPD patients who died during hospitalization in the Department of Pneumonology and Allergology in WMU from 2004 to 2008.

MATERIAL AND METHODS

We analyzed 266 records of patients who had diagnosis of COPD and died during hospitalization (179 [67%] M and 87 [33%] F). The mean age at death was 73 ± 8 years (M 73 ± 8 years, F 74 ± 9 years).

RESULTS

The most frequent cause of death were: COPD exacerbation (n = 81 [30%], F = 32, M = 49), pneumonia (n = 67 [25%], F = 17, M = 50), lung cancer (n = 50 [19%], F = 18, M = 32), ischemic heart disease (n = 20 [7%], F = 5, M = 15), cardiovascular insufficiency (n = 14 [5%], F = 6, M = 8) and other (n = 34 [14%]). The lung cancer was more frequent cause of death in younger patients (p = 0.002), and pneumonia in older (p = 0.02). In COPD patients the following comorbidities were diagnosed: chronic heart failure (n = 169), hypertension (n = 103), ischaemic heart disease (n = 102), diabetes mellitus type 2 (n = 55), renal insufficiency (n = 43), hypertrophy of prostate (n = 36), arteriosclerosis obliterans (n = 28), osteoporosis (n = 19), anaemia (n = 14) and others.

CONCLUSIONS

  1. The most frequent reasons of death were related to respiratory system: COPD exacerbation, pneumonia and lung cancer. 2. The most frequent diseases coexisting with COPD were cardiovascular disease, respiratory insufficiency and diabetes mellitus.
摘要

引言

慢性阻塞性肺疾病(COPD)是美国第四大致死原因,预计到2020年将成为第三大致死原因。人们认为,心血管疾病、骨质疏松症、恶病质、贫血等一些疾病是COPD的全身性后果。一些数据表明,合并症在重度COPD患者中比在对照组中更常见,且与严重的健康后果相关。关于肺外合并症或肺部并发症是否是COPD患者死亡的主要原因存在争议。本研究的目的是分析2004年至2008年在西密歇根大学肺病与过敏科住院期间死亡的COPD患者的死亡率和合并症情况。

材料与方法

我们分析了266例诊断为COPD且在住院期间死亡的患者记录(男性179例[67%],女性87例[33%])。平均死亡年龄为73±8岁(男性73±8岁,女性74±9岁)。

结果

最常见的死亡原因是:COPD急性加重(n = 81例[30%],女性32例,男性49例)、肺炎(n = 67例[25%],女性17例,男性50例)、肺癌(n = 50例[19%],女性18例,男性32例)、缺血性心脏病(n = 20例[7%],女性5例,男性15例)、心血管功能不全(n = 14例[5%],女性6例,男性8例)及其他(n = 34例[14%])。肺癌在年轻患者中是更常见的死亡原因(p = 0.002),而肺炎在老年患者中更常见(p = 0.02)。在COPD患者中诊断出以下合并症:慢性心力衰竭(n = 169例)、高血压(n = 103例)、缺血性心脏病(n = 102例)、2型糖尿病(n = 55例)、肾功能不全(n = 43例)、前列腺肥大(n = 36例)、闭塞性动脉硬化(n = 28例)、骨质疏松症(n = 19例)、贫血(n = 14例)及其他。

结论

  1. 最常见的死亡原因与呼吸系统有关:COPD急性加重、肺炎和肺癌。2. 与COPD共存的最常见疾病是心血管疾病、呼吸功能不全和糖尿病。

相似文献

1
[Mortality and comorbidity in hospitalized chronic obstructive pulmonary disease patients].[住院慢性阻塞性肺疾病患者的死亡率和合并症]
Pneumonol Alergol Pol. 2011;79(5):343-6.
2
[Causes of chronic obstructive pulmonary disease-related death and influencing factors of survival time].[慢性阻塞性肺疾病相关死亡原因及生存时间的影响因素]
Zhonghua Yi Xue Za Zhi. 2011 Mar 29;91(12):824-7.
3
[Analysis of causes of death in patients hospitalized in the department of pneumonology].
Pol Merkur Lekarski. 2012 Apr;32(190):221-4.
4
[Heart failure: critical patients].[心力衰竭:重症患者]
G Ital Cardiol (Rome). 2007 Sep;8(9):568-73.
5
COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.慢性阻塞性肺疾病作为一种具有全身影响的肺部疾病——临床影响、机制及早期干预潜力
COPD. 2008 Aug;5(4):235-56. doi: 10.1080/15412550802237531.
6
[Comorbidities in COPD].[慢性阻塞性肺疾病的合并症]
Arch Bronconeumol. 2010 Dec;46 Suppl 11:20-5. doi: 10.1016/S0300-2896(10)70058-2.
7
[Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease].[重度外周动脉疾病患者慢性阻塞性肺疾病的诊断患病率及困难]
Pol Merkur Lekarski. 2009 Aug;27(158):92-6.
8
[Analysis of deaths caused by obstructive pulmonary diseases in Pomerania province in 2001-2004].[2001 - 2004年波美拉尼亚省阻塞性肺疾病所致死亡分析]
Pneumonol Alergol Pol. 2007;75(1):40-5.
9
[The impact of comorbidities on the length of hospital treatment in patients with chronic obstructive pulmonary disease].[合并症对慢性阻塞性肺疾病患者住院治疗时长的影响]
Pneumonol Alergol Pol. 2011;79(6):388-96.
10
[Mortality from chronic obstructive pulmonary disease: a role of comorbidity].[慢性阻塞性肺疾病的死亡率:合并症的作用]
Klin Med (Mosk). 2008;86(3):18-21.

引用本文的文献

1
Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: protocol of a randomised controlled proof-of-concept trial (APPLE COPD-ICON 2).慢性阻塞性肺疾病患者心血管疾病一级预防中的抗血小板治疗:一项随机对照概念验证试验的方案 (APPLE COPD-ICON 2)。
BMJ Open. 2018 May 26;8(5):e020713. doi: 10.1136/bmjopen-2017-020713.
2
Prevalence of obstructive airway disease by spirometric indices in non-smoker subjects with IHD and HTN.通过肺量计指标评估患有缺血性心脏病(IHD)和高血压(HTN)的非吸烟受试者中阻塞性气道疾病的患病率。
Lung India. 2012 Jul;29(3):241-7. doi: 10.4103/0970-2113.99108.